Eiko Lifesciences Limited - Company Profile

Q: Who are the current directors of Eiko Lifesciences Limited?

The current directors of Eiko Lifesciences Limited are Bhavesh Dhirajlal Tanna, Kajal Dhanpatraj Kothari, Chintan Bharatbhai Doshi, Laxmikant Ramprasad Kabra, Jaid Ismail Kojar, Sumukh Prabhakar Vartak, Rajkumar Govindas Baheti, Hasti Arjav Doshi.

It is a chemicals and materials public limited company based in Thane, Maharashtra, India, established in 1977.

1977 Thane, Maharashtra, India Active

Last Updated: February 06, 2026

Access Report

About Eiko Lifesciences Limited

Eiko Lifesciences Limited, a active public limited company, was established on 07 January 1977 in Thane, Maharashtra, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: L65993MH1977PLC258134. Registered under ROC Roc Mumbai. it is listed on BSE: 540204. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹13.72 Cr.

Formerly known as Ornate Ventures Limited, Narendra Investments (Delhi) Limited. It upholds a compliant status. In 2023, it reported revenue of ₹19.18 Cr and a net worth of ₹29.42 Cr. Its leadership includes Bhavesh Dhirajlal Tanna (Director), Kajal Dhanpatraj Kothari (Director), Laxmikant Ramprasad Kabra (Director). Past directors included Babita Jain, Bharat Bhushan, Virendra Jain. It holds ₹10.00 Cr open charges and ₹8.00 Cr settled loans. Its latest AGM occurred on 05 September 2025, with the balance sheet filed on 31 March 2025. It is based at 604, Centrum, Opp. Tmc Office Near Satkar Grande Hotel, Wagle Estate, Thane, Maharashtra, 400604.

Company Details

CIN/LLPIN
L65993MH1977PLC258134
Registration Number
258134
Incorporation Date
07 January 1977
Authorized Capital
₹20.00 Cr
Paid-Up Capital
₹13.72 Cr
ROC Code
Roc Mumbai
Listing Status
Listed (BSE: 540204)
Company Status
Active

Key Metrics

Authorised Capital ₹ 20.00 Cr as on 06-02-2026
Paid Up Capital ₹ 13.72 Cr as on 06-02-2026
Company Age 49 Year, 1 Month
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 10.00 Cr as on 06-02-2026
Satisfied Charges ₹ 8.00 Cr as on 06-02-2026
Revenue Growth **** -26.49% (FY 2023)
Profit Growth **** 8.93% (FY 2023)
Ebitda **** -26.32% (FY 2023)
Net Worth 2.77% (FY 2023)
Total Assets -11.04% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Eiko Lifesciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Eiko Lifesciences Limited?

Current Directors

Name	Designation	Appointment Date	Status
Bhavesh Dhirajlal Tanna	Director	26 Aug 2013	Current
Kajal Dhanpatraj Kothari	Director	09 Sep 2020	Current
Laxmikant Ramprasad Kabra	Director	26 Aug 2013	Current
Sumukh Prabhakar Vartak	Whole-Time Director	29 Jul 2025	Current
Rajkumar Govindas Baheti	Director	10 Feb 2021	Current
Hasti Arjav Doshi	Director	03 Sep 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	10 Jun 2013	Past
Pramod Abcsdd	Director	17 Oct 2014	Past
Pramod Abcsdd	Director	02 May 2014	Past
Pramod Abcsdd	Director	06 Sep 2012	Past
Pramod Abcsdd	Managing Director	17 Aug 2021	Past
Pramod Abcsdd	Director	01 Mar 2012	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Eiko Lifesciences.

Eiko Lifesciences Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 26.49% decrease. The company also saw a slight improvement in profitability, with a 8.93% increase in profit. The company's net worth moved up by a moderate rise of 2.77%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-26.49%

*******

Revenue from Operations

*******

-27.90%

*******

Total Assets

*******

-11.04%

*******

Profit or Loss

*******

8.93%

*******

Net Worth

*******

2.77%

*******

EBITDA

*******

-26.32%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Eiko Lifesciences?

In 2022, Eiko Lifesciences had a promoter holding of 10.59% and a public holding of 89.41%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹100,000,000.00

Satisfied Charges

₹80,000,000.00

Charges Breakdown by Lending Institutions

Bank Of India : 10.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
30 Sep 2025	Bank Of India	₹10.00 Cr	Open
30 Nov 2024	Others	₹1.00 Cr	Satisfied
13 May 2021	Others	₹7.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Eiko Lifesciences?

Unlock and access historical data on people associated with Eiko Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Eiko Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eiko Lifesciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Eiko Lifesciences

Recent Activity within the Organization

Charges

Progress on A charge with Bank Of India of Rs. 10.00 Cr registered on 30 Sep 2025 with Charge ID 101172739 was modified on 24 Nov 2025. was documented.
24 Nov 2025
Charges

A charge registered on 30 Nov 2024 via Charge ID 101031353 with Others was fully satisfied on 06 Oct 2025. was recorded as a recent event.
06 Oct 2025
Charges

A charge with Bank Of India amounted to Rs. 10.00 Cr with Charge ID 101172739 was registered on 30 Sep 2025. was recorded as a recent event.
30 Sep 2025
Annual General Meeting

The activity Eiko Lifesciences Limited last Annual general meeting of members was held on 05 Sep 2025 as per latest MCA records. was completed.
05 Sep 2025
Director Appointment

The activity Sumukh Prabhakar Vartak was appointed as a Whole-time director was appointed as a Whole-time director on 29 Jul 2025 & has been associated with this company since 7 months 5 days . was completed.
29 Jul 2025
Balance Sheet

Progress on Eiko Lifesciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
31 Mar 2025

Explore recent activity and updates - View Recent Activity